Verastem (VSTM) Research & Development (2011 - 2026)

Verastem has reported Research & Development for 16 years, with the latest figure at $38.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 31.1% year-over-year to $38.2 million; the trailing twelve-month figure through Mar 2026 stood at $123.7 million (up 33.29% YoY), and the FY2025 full-year result was $114.6 million, up 40.9% from the prior year.
• Research & Development for Q1 2026 stood at $38.2 million, up from $31.7 million in the prior quarter.
• The five-year high for Research & Development was $38.2 million in Q1 2026, with the low at $10.7 million in Q4 2022.
• Average Research & Development over 5 years is $20.4 million, with a median of $18.1 million recorded in 2024.
• Peak annual rise in Research & Development reached 109.52% in 2023, while the deepest fall reached 13.4% in 2023.
• Tracing VSTM's Research & Development over 5 years: stood at $10.7 million in 2022, then jumped by 109.52% to $22.5 million in 2023, then decreased by 7.51% to $20.8 million in 2024, then soared by 52.2% to $31.7 million in 2025, then advanced by 20.66% to $38.2 million in 2026.
• The last three Research & Development figures came in at $38.2 million (Q1 2026), $31.7 million (Q4 2025), and $29.0 million (Q3 2025), per Business Quant data.

Peer Comparison